Primary Job Title Executive Vice President, Head of Research and Development Primary Organization 
Ceptaris Therapeutics
Gender Male
Dr. Henkel has spent more than 15 years in the biopharmaceutical industry developing anti-inflammatory, antibacterial, antifungal, and antiviral drugs.
Prior to joining Ceptaris, Dr. Henkel was Executive Vice President of Research and Development at Ception Therapeutics, a biologics company (acquired by Cephalon). He also served as Chief
Medical Officer at Vicuron Pharmaceuticals (acquired by Pfizer) and as a Vice President of GlaxoSmithKline.
Dr. Henkel was Assistant Professor of Internal Medicine and Infectious Diseases at Washington University in St. Louis where he earned his board certifications in both Internal Medicine and Infectious Diseases.
He earned his M.D. and Ph.D. in immunology from Washington University in St. Louis, and his B.S. in Chemistry and Biology from Rhodes College.
